The blood test results, upon review by MyGenom medical doctors, will be shared with the participant, and if applicable, may be the basis for referral. Body composition measurements and also heart rhythm report will also be shared.

If there are any abnormalities in the participant’s heart rhythm report, a referral for further investigation will also be provided. We will be examining the participant’s genes for pathogenic variants as outlined in the American College of Medical Genetics and Genomics (ACMG) guidelines. If any of such variants are detected, we will discuss the need for further evaluation with our Consultant Geneticists and arrange for a consultation if necessary. However, it is important to note that no notification does not imply negative gene test results, as not all genes could be tested for all samples due to technical limitations. The MyGenom study team will not be liable to report underlying genetic findings (if any) due to this technical limitation in a research setting.

The results of the blood test will be relayed through the email provided by the participant. If necessary, the MyGenom doctors may also perform a teleconsultation with the participants.

Individual results will be private and anonymised to protect the participants. The collective data (for example, summaries of including blood test results, questionnaire results, and genomic data) may be published as scientific results in journals, conferences and/or as public dissemination.

The blood test results, similar to the results of any personal health screening, may disclose symptoms or characteristics of diseases or illnesses which may affect the individual’s health insurance in particular. As the genomic data is anonymised and not shared by default, it will not affect insurance or employment status.